MeSH tree: D02.540
Multiple treatments are available for chronic obstructive pulmonary disease (COPD), but identifying which regimen best matches an individual patient's needs remains one of the biggest challenges in care. A new study from ...
Aug 5, 2026
0
3
A study led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by the "la Caixa" Foundation, found no increased risk of miscarriage, stillbirth or major congenital anomalies among women inadvertently ...
Aug 1, 2026
0
6
A world's first scabies control program has drastically reduced cases of the highly contagious parasitic skin disease in the Solomon Islands and Fiji, according to a new study.
Jul 29, 2026
0
7
A new mouse study led by UCLA Health suggests that inflammation during pregnancy can trigger autism-like changes in offspring, but those brain and behavioral effects may be rapidly, though temporarily, reversible in adulthood ...
Jul 23, 2026
0
615
Consuming common foods such as corn chips and popcorn may put pregnant women at risk of exposure to mycotoxins—harmful substances produced by mold—according to Rutgers researchers.
Jul 21, 2026
0
12
Though researchers have been studying the animal deworming drug ivermectin for decades, there is no evidence that it's a safe or effective way to treat cancer in people.
Jul 8, 2026
0
10
Results of the Phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [177Lu]Lu-edotreotide significantly prolonged progression-free survival in patients with metastatic gastroenteropancreatic neuroendocrine ...
Jul 7, 2026
0
6
Soon after Philadelphia hosted America's bicentennial celebrations in late July 1976, more than 200 attendees of the American Legion Convention at the Bellevue-Stratford Hotel in Philadelphia fell ill with pneumonia symptoms, ...
Jun 22, 2026
0
5
A critical problem in treating Clostridioides difficile infections is the possibility that the pathogen develops resistance to fidaxomicin, an antibiotic often prescribed as a first-line treatment. But current methods used ...
Jun 5, 2026
0
3
The U.S. Food and Drug Administration has approved AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) for both the neoadjuvant and adjuvant treatment of patients with human epidermal growth factor receptor 2 (HER2)-positive ...
May 25, 2026
0
10
